107 Results

People

  1. Modi
    Modi
  2. Scheinberg
    Scheinberg
  3. Zeglis
    Zeglis
  4. Finn
    Finn
  5. Jurcic
    Jurcic
  6. Lewis
    Lewis
  7. Mcdevitt
    Mcdevitt
  8. Larson
    Larson
  9. Delaney
    Delaney
  10. Divgi
    Divgi

Groups

  1. Department of Medicine (76)
  2. Solid Tumor Oncology Division (43)
  3. Hematologic Malignancies, Division of (36)
  4. Center for Hematologic Malignancies (28)
  5. GSK Faculty (26)
  6. Radiology, Department of (19)
  7. Breast Medicine Service (18)
  8. Sloan Kettering Institute Faculty (17)
  9. Molecular Pharmacology and Chemistry Program Faculty (16)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  1. "immunoconjugates"
Formats
  1. Journal Article (87)
  2. Review (10)
  3. Correspondence (5)
  4. Editorial (4)
  5. Research Letter (1)
Groups
  1. Department of Medicine (76)
  2. Solid Tumor Oncology Division (43)
  3. Hematologic Malignancies, Division of (36)
  4. Center for Hematologic Malignancies (28)
  5. GSK Faculty (26)
  6. Radiology, Department of (19)

More Groups

People
  1. Shanu Modi (13)
  2. David Scheinberg (10)
  3. Brian Zeglis (9)
  4. Steven Larson (9)
  5. Ronald Finn (7)
  6. Jason Lewis (6)

More People

Years
  1. 2025 (7)
  2. 2024 (22)
  3. 2023 (9)
  4. 2022 (18)
  5. 2021 (4)
  6. 2018 (2)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Journal of Clinical Oncology (7)
  3. Journal of Nuclear Medicine (7)
  4. New England Journal of Medicine (7)
  5. The Oncologist (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. Springer (10)
  3. Oxford University Press (9)
  4. American Society of Clinical Oncology (8)
  5. Massachusetts Medical Society (7)
  6. Nature Publishing Group (7)

More Publishers

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of CD30-expressing germ cell tumors and sex cord stromal tumors with brentuximab vedotin: Identification and report of seven cases
    Journal Article

    Albany, C.; Einhorn, L.; Garbo, L.; Boyd, T.; Josephson, N.; Feldman, D. R.
    The Oncologist (2018)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma
    Journal Article

    Connors, J. M.; Jurczak, W.; Straus, D. J.; Ansell, S. M.; Kim, W. S.; Gallamini, A.; Younes, A.; Alekseev, S.; Illés, Á.; Picardi, M.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
    Journal Article

    Martin, L. P.; Konner, J. A.; Moore, K. N.; Seward, S. M.; Matulonis, U. A.; Perez, R. P.; Su, Y.; Berkenblit, A.; Ruiz-Soto, R.; Birrer, M. J.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Pretargeted imaging and therapy
    Journal Article

    Altai, M.; Membreno, R.; Cook, B.; Tolmachev, V.; Zeglis, B. M.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, C.
    Hematology-American Society of Hematology Education Program (2016)

    Fulltext@MSK | Save
  • The bioconjugation and radiosynthesis of (89)Zr-DFO-labeled antibodies
    Journal Article

    Zeglis, B. M.; Lewis, J. S.
    Journal of Visualized Experiments (2015)

    Fulltext@MSK | Save
  • PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
    Journal Article

    Ansell, S. M.; Lesokhin, A. M.; Borrello, I.; Halwani, A.; Scott, E. C.; Gutierrez, M.; Schuster, S. J.; Millenson, M. M.; Cattry, D.; Freeman, G. J.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event
    Journal Article

    Gandhi, M. D.; Evens, A. M.; Fenske, T. S.; Hamlin, P.; Coiffier, B.; Engert, A.; Moskowitz, A. J.; Ghosh, N.; Petrich, A. M.; Lomasney, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Antibody-drug conjugates in hematologic malignancies
    Journal Article

    Leslie, L. A.; Younes, A.
    American Society of Clinical Oncology Educational Book (2013)

    Fulltext@MSK | Save